世界の医療産業における3Dアプリケーション市場

【英語タイトル】3D Applications in Healthcare Market - 3D Printing and Applications (Surgical Guides, Bioengineering, Implants, Surgical Instruments) technology (Electron Beam Melting, Stereoli thography, Droplet Deposition manufacturing) Raw Material (Metals, Biological Cells, Polymers, Ceramics) Forecast 2014 - 2021

Occams Researchが出版した調査資料(OCAM501017)・商品コード:OCAM501017
・発行会社(調査会社):Occams Research
・発行日:2015年10月3日
・ページ数:100
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名利用)USD4,000 ⇒換算¥420,000見積依頼/購入/質問フォーム
Enterprisewide Price (Global Site License)USD6,000 ⇒換算¥630,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

3D technology is one of the fastest growing markets in the world. 3D imaging market is an offshoot of the traditional diagnostic imaging market. Healthcare industry relies increasingly on the 3D imaging market. 3D printing in healthcare is slowly picking up popularity. The companies working on 3D printing technology are new and mainly focused on research and development. Virtual reality in 3D market is still new and being mainly used to treat posttraumatic stress disorders and phobias.

• 3D diagnostic imaging market is more than 80% of the market in the overall 3D healthcare technology market.
• Currently the main players in 3D diagnostic imaging are GE Healthcare, Siemens, Philips, Toshiba and BARCO.
• The market is well established in all the geographies and North America has the largest market share with almost 50% market share.
• The market has two main players in the 3D printing in healthcare, Stratasys and 3D Systems.
• The 3D printing market is growing in the Asia Pacific region. China has been working a lot in the 3D printing market.
• Currently the US is the largest market with 46% share. 3D printing market is expected to grow at CAGR of 20% by 2021.

This Occams Research Report covers
1. Historical data
2. Revenue forecasts, growth rates and CAGR upto 2021
3. Industry Analysis
4. Competitive Analysis
5. Key geographic growth data
6. Deep profiles top competitive companies

【レポートの目次】

Chap 1. Executive Summary
Chap 2. Market Determinants
2.1. Key Drivers
2.1.1. Better choice over conventional methods
2.1.2. Customized products
2.1.3. Research and Development
2.1.4. Innovative and advanced technologies
2.1.5. FDA nod to 3D innovative technologies
2.2. Restraints
2.2.1. High cost to individual patient
2.2.2. Lower Adoption rate
2.2.3. Regulations
2.3. Opportunity
2.3.1. Increase in joint replacement surgeries
2.3.2. Medical Tourism
2.3.3. Bio printing technology
2.4. Challenges
2.4.1. Transplantation of vital organs
2.4.2. High adoption rate of 3D technology is a challenge
2.4.3. Regulations are a hindrance for 3D technology
Chap 3. 3D technology in healthcare – Application
3.1. 3D Printing
3.2. Implants
3.2.1. Example of use of 3D printing in implant
3.2.2. Advantages of 3D printing in healthcare
3.2.3. Dental Implants
3.2.4. Bio Engineering
3.2.5. Bio medical applications of 3D printing
3.3. 3D printing technologies
3.3.1. Electron beam melting
3.3.2. Laminated object manufacturing
3.3.3. Thermal Inkjet Printing
3.3.4. Selective Laser Sintering
3.3.5. Fused Deposition Modeling (FDM)
3.3.6. Photo polymerization
3.4. Raw material used for 3D printing in healthcare
3.4.1. Bio Ink
3.4.2. Ceramic
3.4.3. Polymers
3.4.4. Acrylonitrile Butadiene Styrene (ABS)
3.4.5. Polyactic Acid (PLA)
3.4.6. Metal
3.5. 3D Imaging
3.5.1. 3D mammography
3.5.2. 3D computed tomography
3.6. Virtual Reality
3.6.1. Use of virtual reality in therapy
Chap 4. Strategies to stay competitive in the 3D technology market in healthcare
4.1. Research and development give rise to innovative technologies
4.2. Stratasys partners with Worrell for new 3D printed medical devices
4.2.1. Organovo and Johnson & Johnson enter into partnership for 3D bio printing drug discovery research
4.2.2. Organovo enters into partnership with the Yale School of Medicine for 3D bioprinted tissue project
4.3. Acquisition gives upper hand over the competitors
4.3.1. Case Study
Chap 5. Geographical analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. Regulations regarding medical devices in Europe
5.2.2. Prevalent diseases in Europe
5.2.3. United Kingdom (UK)
5.2.4. France
5.2.5. Germany
5.3. Asia Pacific (APAC)
5.3.1. China
5.3.1.1. Diseases prevalence in China
5.3.2. Japan
5.3.2.1. Regulations in Japan
5.3.3. India
Chap 6. Company Profiling
6.1. 3 D Imaging
6.1.1. GE Healthcare
6.1.1.1. Overview
6.1.1.2. Strategic Moves
6.1.1.3. SCOT Analysis
6.1.2. Siemens Healthcare
6.1.2.1. Overview
6.1.2.2. Siemens Healthcare Products Portfolio
6.1.2.3. Strategic Moves (2013-14)
6.1.2.4. SCOT Analysis
6.1.3. Philips Healthcare
6.1.3.1. Overview
6.1.3.2. Phillips Healthcare Products Portfolio
6.1.3.3. Strategic Moves (2013-14)
6.1.3.4. SCOT Analysis
6.1.4. Toshiba Medical Systems
6.1.4.1. Overview
6.1.4.2. Toshiba Medical System Products Portfolio
6.1.4.3. Strategic Moves (2013-14)
6.1.4.4. SCOT Analysis
6.1.5. BARCO NV
6.1.5.1. Overview
6.1.5.2. BARCO NV Products Portfolio
6.1.5.3. Strategic Moves (2013-14)
6.1.5.4. SCOT Analysis
6.1.6. Hitachi Medical Systems
6.1.6.1. Overview
6.1.6.2. Hitachi Medical System Products Portfolio
6.1.6.3. Strategic Moves (2013-14)
6.1.6.4. SCOT Analysis
6.2. 3 D Printing
6.2.1. Stryker
6.2.1.1. Overview
6.2.1.2. Strategic Moves (2013-14)
6.2.1.3. SCOT Analysis
6.2.2. 3D Systems Corporation
6.2.2.1. Overview
6.2.2.2. SCOT Analysis
6.2.3. Stratasys
6.2.3.1. Overview
6.2.3.2. SCOT Analysis
6.2.4. Arcam AB
6.2.4.1. Overview
6.2.4.2. SCOT Analysis
6.2.5. Envision TEC GMBH
6.2.5.1. Overview
6.2.5.2. SCOT Analysis
6.2.6. Materialise NV
6.2.6.1. Overview:
6.2.6.2. SCOT Analysis

[Table List]

TABLE 1 Global 3D technology in healthcare market, 2013-2021 (in $million)
TABLE 2 Cost of Implantations, conventional method in 2011
TABLE 3 Global 3D printing in healthcare market, 2013-2021 (in $million)
TABLE 4 Global 3D printing in healthcare market, 2013-2021 (in $million)
TABLE 5 Price comparison between filament of ABS and PLA (2013)
TABLE 6 Global 3D imaging in healthcare market, 2013-2021 (in $million)
TABLE 7 Global 3D imaging in healthcare market, 2013-2021 (in $million)
TABLE 8 Global 3D virtual reality in healthcare market, 2013-2021 (in $million)
TABLE 9 Global 3D technology in healthcare Market, 2013-2021 (in $million)
TABLE 10 North American 3D technology Market, 2013-2021 (in $million)
TABLE 11 Factsheet (US health records 2011 and 2012)
TABLE 12 European 3D technology Market, 2013-2021 (in $million)
TABLE 13 Prevalence of Heart Diseases in UK (2013)
TABLE 14 GE Healthcare’s Product Portfolio

[Figures List]

FIGURE 1 Supply chain in 3 D healthcare 17
FIGURE 2 Global 3D printed implants market, 2013-2021 (in $million)
FIGURE 3 Market Share by regions (2013, in $million)
FIGURE 4 United States 3D technology Market, 2013-2021 (in $million)
FIGURE 5 Canada 3D technology Market, 2013-2021 (in $million)
FIGURE 6 UK 3D technology Market, 2013-2021 (in $million)
FIGURE 7 France 3D technology Market, 2013-2021 (in $million)
FIGURE 8 Germany 3D technology Market, 2013-2021 (in $million)
FIGURE 9 APAC 3D technology Market, 2013-2021 (in $million)
FIGURE 10 China 3D technology Market, 2013-2021 (in $million)
FIGURE 11 Japan 3D technology Market, 2013-2021 (in $million)
FIGURE 12 India 3D technology Market, 2013-2021 (in $million)



【レポートのキーワード】

3Dプリンティング、3Dインプラント、3Dプリンティング技術、3Dプリンティング素材、電子ビーム融解、材料、医療機器、3D画像診断、仮想現実、3Dインプラント、3Dイメージング

★調査レポート[世界の医療産業における3Dアプリケーション市場] (コード:OCAM501017)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の医療産業における3Dアプリケーション市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆